[Advances in the clinical and laboratory studies on methylmalonic aciduria combined with homocysteinemia type cblC].
Yu-Peng
YP
Liu
Yan-Ling
YL
Yang
D000328:Adult; D017668:Age of Onset; D000592:Amino Acid Metabolism, Inborn Errors / Q000150:complications / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D001622:Betaine / Q000008:administration & dosage / Q000627:therapeutic use; D002352:Carrier Proteins / Q000235:genetics* / Q000378:metabolism; D002648:Child; D002681:China / Q000453:epidemiology; D004252:DNA Mutational Analysis; D008401:Gas Chromatography-Mass Spectrometry; D005838:Genotype; D006710:Homocysteine / Q000652:urine; D006801:Humans; D006879:Hydroxocobalamin / Q000008:administration & dosage / Q000627:therapeutic use; D020138:Hyperhomocysteinemia / Q000150:complications / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D007223:Infant; D008764:Methylmalonic Acid / Q000097:blood / Q000652:urine*; D009154:Mutation; D010088:Oxidoreductases; D014805:Vitamin B 12 / Q000378:metabolism
D002352:Carrier Proteins; D006710:Homocysteine; D001622:Betaine; D008764:Methylmalonic Acid; C508359:MMACHC protein, human; D010088:Oxidoreductases; D014805:Vitamin B 12; D006879:Hydroxocobalamin